BIVIW BioVie Inc. - Warrant
NASDAQ · SEC EDGAR'da Görüntüle ↗ kapat Eyl 30, 2026 10-K/10-Q Ağu 13, 2026
$0,30
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,1652 haftanın en düşüğü
$0,5952 haftanın en yükseği
Piyasa Değeri (MRQ)
$2M
P/E
-0.1
Hisse Başına Kâr
$-3.05
rozetleriniz
52 Haftlık Aralık
$0–$1
Analist Derecelendirmesi
·
Fiyat Hedefi
·
P/E
-0.1
ROE
-149.5%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
BIVIW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.30
Piyasa Değeri (MRQ)
$2M
P/E
-0.1
Hisse Başına Kâr
$-3.05
ROE
-149.5%
52 Haftlık Aralık
$0–$1
BIVIW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-3.052019-06-30 → 2026-06-30
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | BIVIW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.1 | · | · | · | |
| F/D (MRQ) | 0.2 | · | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -0.1 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.2 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | BIVIW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -123.3%5Y ort. ≈-137.2% | ≈-137.2% | · | · | |
| ROE | -149.5%5Y ort. ≈-214.4% | ≈-214.4% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | BIVIW | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 3.65Y ort. ≈4.4 | ≈4.4 | · | · | |
| Quick Ratio (Cari Oran) | 2.45Y ort. ≈3.7 | ≈3.7 | · | · | |
| Interest Coverage (Faiz Karşılama Oranı) | -1265.45Y ort. ≈-324.9 | ≈-324.9 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $9M | $23M | $33M | $17M | $3M | $1M | $1M | $370.9K | $466.4K | $37.9K | $4.2K | |
| SG&A Expense | $9M | $9M | $9M | $12M | $10M | $5M | $1M | $1M | $2M | $69.1K | $15.3K | $16.5K | |
| Operating Expenses | $23M | $18M | $32M | $45M | $27M | $138M | $3M | $2M | $2M | $2M | $432.0K | $233.4K | |
| Operating Income | $-23M | $-18M | $-32M | $-45M | $-27M | $-138M | $-3M | $-2M | $-2M | $-2M | $-432.0K | $-233.4K | |
| Interest Expense | $17.9K | $332.7K | $3M | $4M | $2M | $559.5K | $5M | $273 | $41.0K | · | $81 | · | |
| Other Non-op | $578.9K | $524.1K | $59.1K | $-5M | · | · | · | · | · | · | · | · | |
| Net Income | $-22M | $-18M | $-32M | $-50M | $-26M | $-130M | $-17M | $-2M | $-2M | $-1M | $-431.9K | $-233.0K | |
| EPS (Basic) | $-3.05 | $-12.12 | $-73.05 | $-15.47 | $-1.06 | $-14.82 | $-6.85 | $-0.98 | · | · | · | · | |
| EPS (Diluted) | $-3.05 | $-12.12 | $-73.05 | $-15.47 | $-1.06 | $-14.82 | $-6.85 | $-0.98 | · | · | · | · | |
| Shares (Basic) | 7,245,928 | 1,477,372 | 451,853 | 3,248,349 | 24,662,557 | 12,403,159 | 4,929,497 | 2,539,611 | · | · | · | · | |
| Shares (Diluted) | 7,245,928 | 1,477,372 | 451,853 | 3,248,349 | 24,662,557 | 12,403,159 | 4,929,497 | 2,539,611 | · | · | · | · | |
| EBITDA | $-23M | $-18M | $-32M | $-45M | $-27M | $-138M | $-3M | $-2M | $-2M | $-2M | $-432.0K | · |
Bilanço
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $18M | $24M | $19M | $19M | $5M | $37.2K | $339.9K | $45.8K | $5.1K | $123.8K | $267.5K | |
| Prepaid Expense | · | $1M | $204.4K | · | · | · | · | · | · | · | $7.0K | $2.0K | |
| Other Current Assets | · | · | · | · | · | $93.5K | $375.8K | $334.1K | · | · | · | · | |
| Current Assets | $14M | $21M | $24M | $34M | $19M | $5M | $413.0K | $674.1K | $45.8K | $5.1K | $130.7K | $269.5K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $337.8K | · | · | |
| Goodwill | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | · | |
| Intangibles | · | $178.3K | $407.7K | $637.1K | $866.5K | $1M | $1M | $2M | $2M | $2M | $2M | · | |
| Other Non-current Assets | · | · | · | · | $4.6K | · | · | · | · | · | · | · | |
| Total Assets | $14M | $22M | $25M | $35M | $20M | $6M | $2M | $3M | $2M | $2M | $3M | $269.5K | |
| Accounts Payable | $4M | $2M | $4M | $3M | $2M | $996.4K | $1M | $443.5K | $884.2K | $471.0K | $293.6K | $650 | |
| Short-term Debt | · | · | $6M | $9M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $4M | $2M | $9M | $14M | $4M | $996.4K | $24M | $443.5K | $1M | $631.0K | $803.2K | $323.6K | |
| Capital Leases | $184.4K | $275.4K | $349.9K | $42.5K | $87.4K | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $48.4K | · | · | · | · | · | · | · | |
| Total Liabilities | $4M | $3M | $10M | $20M | $16M | $996.4K | $24M | $443.5K | $2M | $1M | $803.2K | · | |
| Total Debt | · | · | $6M | $9M | · | · | $62.5K | · | · | · | · | · | |
| Common Stock | $754 | $192 | $6.2K | $3.6K | $2.5K | $2.2K | $520 | $406 | $9.8K | $9.2K | $8.7K | $8.7K | |
| Retained Earnings | $-374M | $-352M | $-334M | $-301M | $-251M | $-225M | $-41M | $-7M | $-5M | $-2M | $-1M | $-572.4K | |
| Treasury Stock | $29 | $29 | $27 | $2 | · | · | · | · | · | · | · | · | |
| AOCI | · | · | · | $176.6K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $10M | $19M | $16M | $15M | $4M | $5M | $-21M | $2M | $111.2K | $1M | $2M | $-54.1K | |
| Liabilities + Equity | $14M | $22M | $25M | $35M | $20M | $6M | $2M | $3M | $2M | $2M | $3M | $269.5K | |
| Shares Outstanding | 7,542,638 | 1,914,224 | 619,008 | 3,642,895 | 24,984,083 | 22,333,324 | 5,204,392 | 4,058,724 | 98,503,199 | 91,925,000 | 87,160,000 | 87,210,000 |
Nakit Akışı
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $3M | $4M | $6M | $3M | $24.8K | $64.9K | $238.2K | · | · | · | |
| Amort. of Intangibles | $178.3K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $229.4K | $51.0K | · | |
| Operating Cash Flow | $-19M | $-19M | $-28M | $-40M | $-19M | $-10M | $-2M | $-3M | $-621.3K | $-623.6K | $-153.6K | $-65.4K | |
| Investing Cash Flow | · | · | $15M | $-14M | · | · | · | · | · | · | $9.9K | · | |
| Stock Issued | $10M | $16M | $28M | $49M | $19M | $16M | · | · | $447.0K | $480.0K | · | · | |
| Net Stock Activity | $10M | $16M | $28M | $49M | $19M | $16M | · | · | $345.0K | $480.0K | · | · | |
| Financing Cash Flow | $10M | $13M | $18M | $55M | $33M | $15M | $1M | $3M | $662.0K | $505.0K | $-5 | · | |
| Net Change in Cash | · | · | · | · | · | $4M | $-302.7K | $294.1K | $40.7K | $-118.6K | $-143.7K | $-65.4K |
Kârlılık
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -123.3% | -75.0% | -106.5% | -182.0% | -199.4% | -3203.9% | -716.0% | -88.3% | -107.2% | -52.3% | -28.9% | -77.4% | |
| ROE | -149.5% | -81.7% | -186.6% | -271.2% | -382.9% | -1583.4% | 172.2% | -99.4% | -383.8% | -86.6% | -46.4% | -397.4% |
Likidite ve Solventlik
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 9.1 | 2.6 | 2.3 | 4.5 | 4.6 | 0.0 | 1.5 | 0.0 | 0.0 | 0.2 | 0.8 | |
| Quick Ratio | 2.4 | 7.7 | 2.5 | 1.3 | 4.5 | 4.5 | 0.0 | 0.8 | 0.0 | 0.0 | 0.2 | 0.8 | |
| Debt / Equity | · | · | 0.4 | 0.6 | · | · | -0.0 | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | -1265.4 | · | -11.1 | -10.5 | -12.6 | -246.8 | -0.6 | -9145.0 | -57.9 | · | -5333.7 | · |
Hisse Başına
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.36 | $9.93 | $2.50 | $0.42 | $0.15 | $0.23 | $-4.13 | $0.00 | $0.00 | $0.01 | $0.02 | $-0.00 | |
| Cash Flow / Share | $-2.63 | $-12.88 | $-6.18 | $-1.24 | $-0.77 | $-0.84 | $-0.33 | · | · | · | · | · | |
| Cash / Share | $1.19 | $9.17 | $3.85 | $0.53 | $0.75 | $0.20 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-3.05 | $-12.12 | $-73.05 | $-15.47 | $-1.06 | $-14.82 | $-6.85 | $-0.98 | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-22M | $-18M | $-32M | $-50M | $-26M | $-130M | $-17M | $-2M | $-2M | $-1M | $-431.9K | $-233.0K | |
| Market Cap | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -871.4% | · | · | · | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $3M | $4M | $3M | $1M | $1M | $5M | $2M | $2M | $6M | $6M | $9M | $8M | $11M | $7M | $7M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | $4M | $2M | |
| Operating Expenses | $6M | $5M | $6M | $5M | $4M | $3M | $7M | $4M | $5M | $8M | $9M | $11M | $11M | $14M | $11M | $9M | |
| Operating Income | $-6M | $-5M | $-6M | $-5M | $-4M | $-3M | $-7M | $-4M | $-5M | $-8M | $-9M | $-11M | $-11M | $-14M | $-11M | $-9M | |
| Interest Expense | $4.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $66.7K | $256.0K | · | $628.7K | $820.6K | $1M | $1M | $1M | $1M | $1M | |
| Other Non-op | $73.9K | $115.1K | $192.8K | $197.0K | $173.9K | $199.8K | $180.3K | $-29.9K | $-150.5K | $-335.8K | $380.0K | $165.4K | $2M | $-1M | $-4M | · | |
| Net Income | $-6M | $-5M | $-6M | $-5M | $-3M | $-3M | $-7M | $-4M | $-5M | $-8M | $-8M | $-11M | $-9M | $-15M | $-16M | $-10M | |
| EPS (Basic) | $-0.60 | $-0.70 | $-0.77 | $-0.98 | $0.94 | $-1.51 | $-4.55 | $-7.00 | $-65.93 | $-2.00 | $-2.20 | $-2.92 | $-14.16 | $-0.43 | $-0.50 | $-0.38 | |
| EPS (Diluted) | $-0.60 | $-0.70 | $-0.77 | $-0.98 | $0.94 | $-1.51 | $-4.55 | $-7.00 | $-65.93 | $-2.00 | $-2.20 | $-2.92 | $-14.16 | $-0.43 | $-0.50 | $-0.38 | |
| Shares (Basic) | · | 7,543,923 | 7,920,795 | 5,214,355 | · | 1,850,722 | 1,571,725 | 639,836 | · | 4,480,108 | 3,817,077 | 3,672,490 | · | 35,325,580 | 31,168,826 | 27,212,445 | |
| Shares (Diluted) | · | 7,543,923 | 7,920,795 | 5,214,355 | · | 1,850,722 | 1,571,725 | 639,836 | · | 4,480,108 | 3,817,077 | 3,672,490 | · | 35,325,580 | 31,168,826 | 27,212,445 | |
| EBITDA | · | $-5M | $-6M | $-5M | · | $-3M | $-7M | $-4M | · | $-8M | $-9M | $-11M | · | $-14M | $-11M | $-9M |
Bilanço
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $13M | $21M | $25M | $18M | $23M | $24M | $20M | $24M | $30M | $20M | $21M | $19M | $31M | $46M | $21M | |
| Prepaid Expense | · | · | · | $873.9K | $1M | $569.5K | $275.8K | · | $204.4K | · | · | · | · | · | · | · | |
| Current Assets | $14M | $17M | $22M | $26M | $21M | $24M | $25M | $20M | $24M | $31M | $21M | $23M | $34M | $44M | $46M | $22M | |
| Goodwill | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | $345.7K | |
| Intangibles | · | $6.3K | $63.7K | $121.0K | $178.3K | $235.7K | $293.0K | $350.4K | $407.7K | $465.1K | $522.4K | $579.8K | $637.1K | $694.4K | $751.8K | $809.1K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $4.6K | $4.6K | $4.6K | |
| Total Assets | $14M | $18M | $23M | $27M | $22M | $25M | $26M | $21M | $25M | $32M | $21M | $24M | $35M | $45M | $47M | $23M | |
| Accounts Payable | $4M | $2M | $3M | $2M | $2M | $2M | $1M | $3M | $4M | $4M | $4M | $3M | $3M | $5M | $3M | $3M | |
| Short-term Debt | · | · | · | · | · | · | · | $3M | $6M | $8M | $10M | $9M | $9M | $6M | · | · | |
| Current Liabilities | $4M | $2M | $3M | $2M | $2M | $3M | $1M | $7M | $9M | $12M | $14M | $13M | $14M | $16M | $8M | $4M | |
| Capital Leases | $184.4K | $213.3K | $232.5K | $254.4K | $275.4K | $295.7K | $314.9K | $332.7K | $349.9K | $366.4K | $17.6K | $30.2K | $42.5K | $54.5K | $65.8K | $76.8K | |
| Total Liabilities | $4M | $2M | $3M | $2M | $3M | $3M | $2M | $7M | $10M | $13M | $14M | $16M | $20M | $23M | $21M | $17M | |
| Total Debt | · | · | · | · | · | · | · | $3M | · | $8M | $10M | $9M | · | $6M | · | · | |
| Common Stock | $754 | $754 | $754 | $754 | $192 | $7.5K | $7.5K | $6.4K | $6.2K | $6.1K | $4.0K | $3.7K | $3.6K | $3.6K | $3.4K | $3.0K | |
| Retained Earnings | $-374M | $-369M | $-363M | $-357M | $-352M | $-349M | $-346M | $-339M | $-334M | $-329M | $-320M | $-312M | $-301M | $-292M | $-277M | $-261M | |
| Treasury Stock | $29 | $29 | $29 | $29 | $29 | $29 | $27 | $27 | $27 | $5 | $2 | $2 | $2 | $2 | · | · | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | · | $176.6K | $16.5K | · | · | |
| Stockholders' Equity | $10M | $16M | $19M | $25M | $19M | $22M | $24M | $14M | $16M | $19M | $7M | $8M | $15M | $22M | $26M | $6M | |
| Liabilities + Equity | $14M | $18M | $23M | $27M | $22M | $25M | $26M | $21M | $25M | $32M | $21M | $24M | $35M | $45M | $47M | $23M | |
| Shares Outstanding | 7,542,638 | 7,541,839 | 7,540,734 | 7,537,479 | 1,914,224 | 18,517,376 | 18,451,981 | 7,956,660 | 619,008 | 60,969,846 | 39,843,834 | 36,899,880 | 3,642,895 | 36,131,311 | 34,504,332 | 30,165,319 |
Nakit Akışı
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $256.7K | $2M | $197.3K | $268.4K | $352.8K | $338.4K | $385.3K | $118.9K | $705.1K | $690.9K | $619.7K | $808.0K | $742.4K | $889.0K | $2M | $878.6K | |
| Amort. of Intangibles | $6.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | $57.3K | |
| Operating Cash Flow | $-4M | $-7M | $-4M | $-3M | $-6M | $-1M | $-9M | $-4M | $-4M | $-6M | $-6M | $-12M | $-11M | $-12M | $-8M | $-9M | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $15M | $-2M | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $10M | $0 | $0 | $13M | $2M | $0 | $18M | $7M | $2M | $1M | $10M | $33M | $6M | |
| Net Stock Activity | · | · | · | $10M | · | · | · | $2M | · | · | · | $2M | · | · | · | $6M | |
| Financing Cash Flow | $0 | $0 | $0 | $10M | $0 | $0 | $13M | $-240.9K | $-2M | $16M | $5M | $-594.2K | $1M | $10M | $33M | $12M |
Kârlılık
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | -25.0% | -25.2% | -21.2% | · | -9.9% | -30.1% | -18.4% | · | -21.0% | -24.5% | -46.0% | · | -42.1% | -39.7% | -46.5% | |
| ROE | · | -28.2% | -28.1% | -26.1% | · | -13.7% | -45.3% | -38.4% | · | -39.7% | -50.1% | -158.6% | · | -95.0% | -74.5% | -79.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 10.0 | 7.2 | 15.8 | · | 9.3 | 16.9 | 2.9 | · | 2.4 | 1.5 | 1.7 | · | 2.8 | 5.9 | 5.3 | |
| Quick Ratio | · | 7.7 | 6.8 | 15.2 | · | 9.1 | 16.8 | 2.9 | · | 2.4 | 1.4 | 1.6 | · | 2.0 | 5.9 | 5.2 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.2 | · | 0.4 | 1.4 | 1.2 | · | 0.3 | · | · | |
| Interest Coverage | · | -902.5 | -1049.5 | · | · | · | · | -16.1 | · | -12.3 | -10.7 | -10.8 | · | -12.7 | -10.9 | -8.4 |
Hisse Başına
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.07 | $2.55 | $3.31 | · | $1.18 | $1.30 | $1.77 | · | $0.31 | $0.19 | $0.20 | · | $0.60 | $0.76 | $0.20 | |
| Cash Flow / Share | · | · | · | $-0.58 | · | · | · | $-0.56 | · | · | · | $-0.33 | · | · | · | $-0.34 | |
| Cash / Share | · | $1.74 | $2.72 | $3.31 | · | $1.25 | $1.32 | $2.52 | · | $0.50 | $0.51 | $0.57 | · | $0.87 | $1.33 | $0.70 | |
| EPS (TTM) | · | $-1.51 | $-2.32 | $-6.10 | · | $-78.99 | $-79.48 | $-77.13 | · | $-21.28 | $-19.71 | $-18.01 | · | $-1.64 | $-1.49 | $-1.21 |
Değerleme (TTM)
| Metrik | Eğilim | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-20M | $-17M | $-18M | · | $-19M | $-24M | $-26M | · | $-36M | $-43M | $-51M | · | $-49M | $-41M | $-31M | |
| Market Cap | · | $3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | -0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | -431.4% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Net Gelir | $-22M | $-18M | $-32M | $-50M | $-26M |
| Seyreltilmiş Hisse Başı Kâr | $-3.05 | $-12.12 | $-73.05 | $-15.47 | $-1.06 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | 0.4 | 0.6 | · |
| Cari Oran | 3.6 | 9.1 | 2.6 | 2.3 | 4.5 |
| Cari Oran | 2.4 | 7.7 | 2.5 | 1.3 | 4.5 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 8 dosya · $1.1M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
8
Tutulan Değer
$1.1M
Yeni pozisyonlar
0
Çıkan pozisyonlar
0
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 0 (-1 önceki Ç'ye göre) | 0 (-2 önceki Ç'ye göre) | 2 (+2 önceki Ç'ye göre) | 1 (-2 önceki Ç'ye göre) | +150K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Diametric Capital, LP | $337.500 | 750.000 | 31,52% | Hisse senetleri |
| Warberg Asset Management LLC | $276.042 | 613.426 | 25,78% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $225.000 | 500.000 | 21,01% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $83.979 | 186.621 | 7,84% | Hisse senetleri |
| MYDA Advisors LLC | $71.910 | 159.800 | 6,72% | Hisse senetleri |
| HEIGHTS CAPITAL MANAGEMENT, INC | $40.500 | 90.000 | 3,78% | Hisse senetleri |
| ARMSTRONG ADVISORY GROUP, INC | $29.655 | 65.900 | 2,77% | Hisse senetleri |
| TWO SIGMA SECURITIES, LLC | $6.248 | 13.884 | 0,58% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| DO CUONG V, Do & Rickles Investments, LLC | 25 Mart 2026 | 5,03% | İlk başvuru | Pasif yatırım | SEC |
| ACUITAS GROUP HOLDINGS, LLC, TERREN S. PEIZER | 30 Haziran 2025 | 15,80% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 7 içeriden öğrenenler · 3 yöneticiler · 5 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| DO CUONG V | President & CEO | 27 Ağustos 2026 P | 16.117 | 1 | 0 | $31.637 |
| Joanne Wendy Kim | Chief Financial Officer | 28 Ağustos 2026 P | 3.441 | 1 | 0 | $5.450 |
| Joseph M Palumbo | Chief Medical Officer | 28 Ağustos 2026 P | 6.036 | 1 | 0 | $10.461 |
| Amy Suzon Chappell | Yönetim kurulu üyesi | 28 Ağustos 2026 P | 727 | 1 | 0 | $1.570 |
| Robert J Hariri | Yönetim kurulu üyesi | 05 Nisan 2022 A | · | 0 | 0 | $0 |
| Richard J Berman | Yönetim kurulu üyesi | 05 Nisan 2022 A | · | 0 | 0 | $0 |
| Steve Gorlin | Yönetim kurulu üyesi | 05 Nisan 2022 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-K dosyalandı Ağu 13, 2026